European Heart Journal Advance Access originally published online on June 2, 2006
European Heart Journal 2006 27(14):1754-1755; doi:10.1093/eurheartj/ehl057
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Aspirin and clopidogrel resistance: an emerging clinical entity: reply
Department of Cardiovascular Medicine
Interventional Cardiology
Cleveland Clinic Foundation
9500 Euclid Avenue, F25
Cleveland
OH 44195
USA
Department of Cardiovascular Medicine
Interventional Cardiology
Cleveland Clinic Foundation
9500 Euclid Avenue, F25
Cleveland
OH 44195
USA
Tel: +1 216 445 4042
Fax: +1 216 444 8050
E-mail address: bhattd@ccf.org
| The first 10% of the full text of this article appears below. |
We are glad the authors of this letter to the editor found our article interesting.1 They raise some valid points. However, it was not our intent to claim that